EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rhinosinusitis as a Modifiable Determinant of Asthma Control in Children: A Narrative Review

Despoina Koumpagioti, Barbara Boutopoulou, Maria Tsouprou, Kostas N. Priftis, Konstantinos Douros, Dafni Moriki

Sinusitis · 01.07.2026 · 10 (2) · 16

DOI: 10.3390/sinusitis10020016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sinusitis, online erschienen am 01.07.2026. Verfasst von Despoina Koumpagioti und 5 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paediatric rhinosinusitis (RS), particularly chronic rhinosinusitis (CRS), is a common inflammatory condition with a significant impact on quality of life and a well-recognized association with asthma within the framework of united airway disease. This review aims to evaluate the impact of RS, mainly CRS, on asthma control in children and explore its role as a modifiable determinant. Mechanistically, RS and asthma share key pathophysiological features, including type 2 inflammation, epithelial barrier dysfunction, and airway microbiome dysbiosis, supporting the concept of a unified inflammatory process across the respiratory tract. Clinically, epidemiological data demonstrate a high prevalence of coexisting RS and asthma, with consistent associations with poorer asthma control, increased disease severity, and higher exacerbation burden, even in cases of subclinical sinonasal inflammation. Available observational evidence suggests that appropriate management of CRS, including medical therapy and, in selected cases, surgical intervention, may improve asthma outcomes such as symptom control and lung function. Targeted biologic therapies have shown clinical benefit in adolescents with CRS with nasal polyps (CRSwNP) and high type 2 inflammation, although paediatric data remain limited. However, the existing evidence is predominantly based on small, heterogeneous, observational studies. RS therefore represents a potentially treatable trait in paediatric asthma, warranting systematic evaluation in children with difficult-to-treat disease. Further prospective and interventional studies are needed to clarify causality and define the impact of RS on long-term outcomes.

Zitieren

APA

Koumpagioti, D., Boutopoulou, B., Tsouprou, M., Priftis, K. N., Douros, K., & Moriki, D. (2026). Rhinosinusitis as a Modifiable Determinant of Asthma Control in Children: A Narrative Review. Sinusitis, 10(2), 16. https://doi.org/10.3390/sinusitis10020016

Vancouver

Koumpagioti D, Boutopoulou B, Tsouprou M, Priftis KN, Douros K, Moriki D. Rhinosinusitis as a Modifiable Determinant of Asthma Control in Children: A Narrative Review. Sinusitis. 2026;10(2):16. doi:10.3390/sinusitis10020016

BibTeX
@article{Koumpagioti2026,
  author = {Koumpagioti, Despoina and Boutopoulou, Barbara and Tsouprou, Maria and Priftis, Kostas N. and Douros, Konstantinos and Moriki, Dafni},
  title = {Rhinosinusitis as a Modifiable Determinant of Asthma Control in Children: A Narrative Review},
  journal = {Sinusitis},
  year = {2026},
  volume = {10},
  number = {2},
  pages = {16},
  doi = {10.3390/sinusitis10020016}
}
Kostenlos starten →